Proudly Canadian
Proudly Canadian It is a once-weekly injection that activates GLP-1 and GIP pathways to reduce appetite, increase fullness, and support substantial weight loss.
It’s specifically approved for chronic weight management and is used alongside diet and exercise.
Unlimited doctor follow ups
Prescription delivery to your pharmacy
Personalized treatment plan
Convenient treatment options
Affordable pricing with no hidden fees
Unlimited doctor follow ups
Prescription delivery to your pharmacy
Personalized treatment plan
Convenient treatment options
Affordable pricing with no hidden fees
Zepbound is the newest and very effective weight loss medication currently approved in Canada. It is a once-weekly injectable that works on two hormonal pathways instead of one — making it uniquely effective.
Zepbound acts as dual agonists — it activates both GLP-1 and GIP receptors. This dual action appears to produce greater weight loss and improved insulin sensitivity compared to medications that only contain GLP-1. By targeting both hunger pathways simultaneously, Zepbound delivers stronger appetite suppression than single-hormone medications.
A once-weekly subcutaneous injection. Starting at 2.5 mg weekly for 4 weeks, then increased to 5 mg, and titrated upward in 2.5 mg increments every 4 weeks (case to case basis) up to a maximum of 15 mg per week.
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
